SUS Relative Valuation - Surgical Science Sweden AB - Alpha Spread
S

Surgical Science Sweden AB
STO:SUS

Watchlist Manager
Surgical Science Sweden AB
STO:SUS
Watchlist
Price: 119.1 SEK -1.41% Market Closed
Market Cap: 6.1B SEK
Have any thoughts about
Surgical Science Sweden AB?
Write Note
Section:
 

Relative Value

The Relative Value of one SUS stock under the Base Case scenario is 209.65 SEK. Compared to the current market price of 119.1 SEK, Surgical Science Sweden AB is Undervalued by 43%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SUS Relative Value
Base Case
209.65 SEK
Undervaluation 43%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Valuation Multiples

7.2
P/S
P/S
Price to Sales
7.2
vs History
96
vs Industry
16
Median 3Y
10.8
Median 5Y
19.8
Industry
2.3
Forward
6.5
More Details
30.7
P/E
P/E
Price to Earnings
30.7
vs History
92
vs Industry
16
Median 3Y
51.6
Median 5Y
93.7
Industry
22.4
Forward
34.4
More Details
40.2
P/OCF
P/OCF
Price to OCF
40.2
vs History
77
vs Industry
11
Median 3Y
64.1
Median 5Y
64.1
Industry
14.4
More Details
58.8
P/FCFE
P/FCFE
Price to FCFE
58.8
vs History
53
vs Industry
13
Median 3Y
61.7
Median 5Y
61.7
Industry
20.8
More Details
1.3
P/B
P/B
Price to Book Value
1.3
vs History
98
vs Industry
51
Median 3Y
2
Median 5Y
2.8
Industry
2.1
More Details
6.5
EV/S
EV/S
Enterprise Value to Sales
6.5
vs History
98
vs Industry
16
Median 3Y
10.3
Median 5Y
19.4
Industry
2.4
Forward
5.8
More Details
9.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
9.4
vs History
98
vs Industry
19
Median 3Y
15.3
Median 5Y
24.4
Industry
4.8
More Details
36.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
36.6
vs History
85
vs Industry
7
Median 3Y
48.8
Median 5Y
83.2
Industry
12.5
Forward
19.1
More Details
36.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
36.6
vs History
92
vs Industry
9
Median 3Y
49.4
Median 5Y
101.7
Industry
16.9
Forward
24
More Details
35.8
EV/OCF
EV/OCF
Enterprise Value to OCF
35.8
vs History
80
vs Industry
13
Median 3Y
60.8
Median 5Y
60.8
Industry
14.2
More Details
53.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
53.8
vs History
74
vs Industry
12
Median 3Y
79.8
Median 5Y
79.8
Industry
18.1
More Details
1.3
EV/IC
EV/IC
Enterprise Value to IC
1.3
vs History
98
vs Industry
47
Median 3Y
1.9
Median 5Y
2.7
Industry
1.8
More Details

Multiples Across Competitors

SUS Competitors Multiples
Surgical Science Sweden AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Surgical Science Sweden AB
STO:SUS
6.1B SEK 7.2 30.7 36.6 36.6
US
Abbott Laboratories
NYSE:ABT
198.1B USD 4.9 35.7 20.4 30.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
173.3B USD 22.9 82.8 68.6 85.7
US
Stryker Corp
NYSE:SYK
138.7B USD 6.5 40.2 25.9 31.6
US
Boston Scientific Corp
NYSE:BSX
123.1B USD 8.1 67.3 32.6 47.2
IE
Medtronic PLC
NYSE:MDT
115.1B USD 3.5 29.3 15.2 21.7
US
Becton Dickinson and Co
NYSE:BDX
68B USD 3.4 48.1 15.4 27.4
DE
Siemens Healthineers AG
XETRA:SHL
55.5B EUR 2.5 29.8 17.1 24.9
US
IDEXX Laboratories Inc
NASDAQ:IDXX
42.8B USD 11.3 50.7 35.9 39.9
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
41.3B USD 2.1 26.1 15.6 19.4
US
Edwards Lifesciences Corp
NYSE:EW
40.5B USD 6.8 27.5 21.6 23.5

See Also

Summary
SUS intrinsic value, competitors valuation, and company profile.
DCF Valuation
SUS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SUS stock valuation using valuation multiples.
Wall Street Estimates
SUS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SUS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 179,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.